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ABSTRACT 
 
 Several Saccharomyces cerevisiae mutant tRNAQ2 species (glutamine 
isoacceptor, CUG anticodon) were synthesized and assayed for aminoacylation activity 
with Saccharomyces cerevisiae glutaminyl-tRNA synthetase.  The derived steady state 
parameters were compared to similar datasets from the literature.  The mutants behaved 
analogously to similar mutant species based on tRNA from Escherichia coli, but with 
slightly relaxed specificity as revealed by comparison of kcat/KM values relative to wild 
type in vitro transcribed tRNA.  Additionally the eukaryotic N-terminal domain 
appendage, as found in Sce glutaminyl-tRNA synthetase, is considered in light of the 
discovery of non-canonical aminoacyl-tRNA synthetase functions, including its role in 
the assembly of the multiple aminoacyl-tRNA synthetase complex. 
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1. INTRODUCTION 
 
i. molecular information in terrestrial life 
 
 The canonical role of nuclear/genetic polynucleotides made from 
deoxyribonucleic acid (DNA) contain the information necessary for the production of 
proteins.  This is initially achieved via transcription of discrete segments of DNA, known 
as genes, into the complementary polynucleotide comprised of ribonucleic acids (RNA), 
commonly referred to as messenger RNA (mRNA).  These mRNAs are subsequently 
translated into protein/polypeptide gene products via the ribosomal assembly, a 
ribonucleoprotein (RNP) complex. 
 Specific interactions between transfer RNA (tRNA) and mRNA facilitate the 
processes of genetic information being translated into peptide/protein product.  The 
nature of these interactions give rise to a phenomenon commonly referred to the genetic 
code.  The letters of this "alphabet" are not simply the single constitutive canonical 
nucleobases (adenine, uridine, cytidine, and guanine), but rather groupings of three 
consecutive nucleobase residues.  These give rise to codons, which are "interpreted" into 
meaning (protein) by the translational apparatus of the cell.  Most of the 64 codons 
correspond to one of the twenty canonical amino acid monomers, but three are reserved 
as signals indicating that transcription should terminate and mRNA be released.  Just 
downstream of transcription factor promoter sequence, the "START" codon of a 
contiguous DNA sequence coding for gene product (peptide/protein) regions also serves 
as the codon for methionine.  As such, all synthesis of proteins and peptides begin with 
methionine, but in many cases the methionine is subsequently removed by enzymatically 
mediated post-translational modification. 
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 The genetic code is nearly universal, implying that all life on this planet 
ultimately originated from a single form of early life, be it either a single discrete 
universal common ancestor or communal prebiotic entities coexisting, competing, and 
freely exchanging amongst the group.  Codons are not equally distributed amongst the 
twenty amino acids, and as such some amino acids correspond to a single codon (Met, 
Trp), while others correspond to six codons (Leu, Ser, and, Arg).  These give rise to the 
one-box, two-box, etc. codon sets.  While the genetic code rarely varies in amino acid 
meaning. codons are not utilized at the same frequency across the various phyla within 
the three main evolutionary branches of terrestrial life. 
 Assembly of polypeptide is achieved with amino acids delivered to the ribosomal 
assembly via transfer RNA (tRNA).  Amino acids arrive covalently attached to the 2′ or 
3′ hydroxyl oxygen of the tRNA 3′ terminus, where they are subsequently hydrolyzed off 
and covalently added by the ribosome assembly to the C-terminus of the nascent 
polypeptide.  Hybridization between the codon of an mRNA and the anti-codon (reverse 
complement) of tRNA facilitates correct amino acid utilization by the ribosome.  
Ostensibly, in a genome there is at least one tRNA species per the 64 codons, but many 
species possess a wealth of paralogous tRNA genes, all with the same anticodon.  For 
example, Homo sapiens (Hsa) has 26 genes that appear to code for tRNAQ2 (Gln CUG) 
alone (Supplemental data 4). Essentially nothing is understood regarding the role of these 
extra sets in vivo. 
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ii. tRNA commonalities (consensus of shape) 
 
 While tRNAs must have enough structural and sequence diversity to be 
differentiated amongst one another, they are quite similar in secondary and tertiary 
structure.  All tRNAs must be able conform to the ribosome binding pockets for protein 
translation  to proceed.1 The classic depiction of tRNA is via the so-called clover leaf 
structure (Figure 1a) that illustrates the four major arms arising from internal Watson-
Crick (WC) base pairing.  However, tRNAs are replete with non-WC base pairings far 
apart in sequence that, in conjunction with stacking in the core, give rise to the three-
dimensional fold of tRNA that overall resembles an L-shape (Figure 1). 
 
 
Figure 1.1 a) tRNA 2° structure cloverleaf, with standard numbering  b) tRNA 3° fold 
 
 
 tRNA can be thought of as having five major secondary structural features: the 
acceptor stem, the D-stem loop, the anticodon stem loop, the variable loop, and the T-
stem loop.1  The length of the variable loop defines the class of tRNA: shorter variable 
arms define class I tRNAs, while longer variable loops are characteristic of class II 
tRNAs.  While many tRNAs adhere to this general feature set, deviant species with stems 
4 
 
and loops varying in length (or missing altogether) emerge from the massive datasets of 
the modern genomic and bioinformatic sciences.  Many of these non-standard instances 
are found in tRNAs from organellar genomes.1 
 Following the standard numbering system for tRNAs (Figure 1), the bases 
comprising the anticodon are found at N34, N35, and N36 relative to the 5′ terminus.  
These correspond to the reverse complement of the codon found on mRNA, with the 
wobble position being located at N34 (corresponding to complement base of the 
appropriate 3′ mRNA codon residue).  Adhering to the same numbering system, the 
single stranded 3′ terminus invariably consists of C74, C75, and A76 in mature tRNAs.2 
It is at the ubiquitous A76 that amino acid is covalently attached via the sugar hydroxyl 
moiety. 
 
 
iii. aaRSs: chemistry, quality control, and evolutionarily directed multi-purposing 
 
 
 tRNA functions not only as a molecular shuttle, but also participates in one of the 
principal quality control checkpoints of translation: the covalent attachment of cognate 
amino acid to the correct tRNA by an aminoacyl-tRNA synthetase (aaRS).   This family 
of proteins, organized into two main classes (I & II), demonstrate remarkable diversity in 
structure and organization across species and classes, but all contain highly conserved 
catalytic cores (within their class) that effect same fundamental chemistry, between 
amino acid and tRNA.  All aaRSs achieve "charging" of tRNA by means of a two step 
reaction pathway (Scheme 1).  In the first step, an aaRS activates amino acid by 
hydrolysis of rATP, with concomitant release of inorganic pyrophosphate (PPi).  As 
rAMP is a good leaving group, the 3′ terminal A76 covalently attaches aminoacyl moiety 
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via attack of the 2′ or 3′ OH (Class I or Class II aaRS, respectively) group of the 
backbone carboxyl carbon of the adenylated amino acid intermediate, with loss of 
rAMP.2 
 
 
 
Scheme 1.  Generic mechanism of tRNA aminoacylation via class II aaRSs (top) and class I 
aaRSs (bottom) 
 
 
 Cells produce protein with an estimated error rate of 103-104,3, and much of this 
fidelity comes from the ability of aaRSs to selectively charge cognate tRNA with cognate 
amino acid.  This is achieved by a vast species and aaRS dependent toolbox including 
direct readout of consensus tRNA residue moieties via the major and minor grooves, 
kinetic mechanism, induced fit, negative determinants, obligate quaternary structure 
beyond the simple 1:1 aaRS:tRNA complex, and indirect readout of tRNA shape via 
direct and solvent mediated protein-RNA contacts (Figure 2).  Additionally there are 
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several examples of aaRSs that possess editing domains that are capable of further quality 
check via hydrolysis of activated non-cognate adenylated amino acid (pre-transfer 
editing) or via hydrolysis of the non-cognate aminoacyl moiety from tRNA just after 
erroneous attachment (post-transfer editing).4 
 
 
 
Figure 2.5  Class I (left) and class II (right) common tRNA identity elements 
 
 
 In species- and organelle-dependent fashion, proper charging of tRNA is 
sometimes achieved via an indirect pathway.  In these instances, non-cognate amino acid 
is "incorrectly" incorporated into tRNA corresponding to another amino acid.  Another 
protein subsequently effects chemistry upon the mischarged aminoacyl-tRNA at the 
precursor amino acid side chain, yielding the correctly charged aminoacyl-tRNA.  One 
example is glutaminyl-tRNAQx (Gln-tRNAQ, representing both Gln anticodons: UUG and 
CUG) synthesis in Archaea, organelles, and most bacteria outside Proteobacteria; these 
organisms' genomes lack a glutaminyl(Q)-tRNA synthetase (QRS).  However, they still 
incorporate glutamine into their proteins and utilize the glutamine codon set.  In many of 
these cases the solution comes by way of a non-discriminating (ND) glutamyl(E)-tRNA 
synthetase (ERS) that lacks the ability to distinguish between tRNAQ and tRNAE species, 
indiscriminately charging both with glutamate.2  Mischarged glutamyl-tRNAQ (Glu-
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tRNAQ) is transamidated to Gln-tRNAQ by a separate enzymatically catalyzed reaction.  
For example, the mitochondria in yeast utilize this pathway by importation of the 
cytosolic nuclear-encoded ND-ERS, which charges mitochondrial tRNAQ with 
glutamate.  The tRNA-dependent amidotransferase assembly GatFAB then effects the 
transamidation of Glu-tRNAQ to Gln-tRNAQ.6  Erroneous incorporation of incorrect 
amino acid from mischarged tRNA into nascent polypeptide is limited by discrimination 
from elongation factor channeling.7 
 Beyond similar tertiary folds and (generally) highly conserved active site resides, 
the aaRSs are amongst the most rapidly evolved group of enzymes across phylogenetic 
distances.  The aaRSs are replete with domain appendages, insertions/deletions (indel), 
and functional expansions.8  Furthermore, many human aaRSs have been implicated in a 
number of cytoplasmic, nuclear, and extracellular roles including cytokine signaling, 
apoptosis, tumorigenesis, inflammation, translational suppression, transcriptional 
regulation, and more.9 
 The evolutionary expansion of aaRS function is perhaps most dramatically 
exhibited by the emergence of the multiple aminocyl-tRNA synthetase complex (MARS) 
found in some Eukarya, including humans.10  The core complex consists of nine aaRSs 
and at least11 three accessory/scaffold proteins, hitherto referenced as aminoacyl-tRNA 
complex-interacting multifunctional protein (AIMP).  It appears that MARS exists in 
loose association with the ribosome, in part through extensive interactions with 
elongation factors.12 However, there are possibly other weakly interacting partners.13  The 
AIMPs have been implicated in a broad array of regulatory and signaling roles similar in 
scope to the non-canonical functions adopted in eukaryotic aaRSs.14 
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iv. Eco QRS 
 
 The enzyme responsible for glutaminyl-tRNAQ synthesis in Escherichia coli 
(Eco) has been extensively studied15 using numerous techniques including (but not 
limited to) crystallographic16–19 and kinetic20,21 methods.  The 553 amino acid, 63 kDa 
monomeric protein consists of four principal domains with specific roles (Figure 3).   
 
 
 
Figure 3. Eco QRS, colored according to description in text, in complex with tRNAQ2  
(PDB id 1QTQ) 
 
 
The active site lies closer to the N-terminus, comprising the two halves of the Rossmann 
fold (RF, residues 8-100;  210-270; orange) separated by the acceptor stem binding 
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domain (ASB, residues 101-209; lime green).  The helical subdomain (HS, residues 271-
339; purple).  The anticodon binding domain (ACB, residues 340-547) is made up by two 
subdomains, the proximal β-barrel (residues 340-346; 461-547; mauve) separated by the 
distal β-barrel (residues 347-460; pale green).  Of interest, the anticodon binding domain 
shares structural homology with Ribosomal protein L25.22 The seven N-terminal residues 
and six C-terminal residues have not demonstrated ordered crystal structure.15 
 Eco QRS has been visualized via X-ray crystallography as both tRNA co-crystal 
(with various ligation partners) and apoenzyme.16  Rearrangements of Eco QRS upon 
tRNA binding can be demonstrated via structural alignments (Figure 4).  These shifts of 
structure are required for the active site residues of Eco QRS to adopt a catalytically 
proficient arrangement.15  As such, in the absence of bound tRNAQ Eco QRS, like only a 
few other Class I aaRSs, is unable to catalyze the first step in aminoacylation,23 the 
activation of amino acid with rATP.  As A76 of tRNAQx participates in proper orientation  
of rATP substrate in the active site cleft,2 the 1:1 QRS:tRNAQx complex can be 
considered an obligate ribonucleoprotein. 
 The identity elements required for proper Eco QRS recognition of tRNAQ have 
been scrutinized.  The identity and role of specific residues in both biopolymers are well 
established24 (see Table 1, Results & Discussion).  There may yet be unknown 
determinants, as many studies have used unmodified in vitro transcribed tRNA, and the 
shape of the 3° tRNA fold have been shown to affect aminoacylation even when the full 
of complement of identity nucleotides are still present.25  In short, the most important  
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Figure 4. Structural rearrangements of Eco QRS upon tRNA binding 
top, detail of structural alignments for several Eco QRS structures, colored by RMSD; 
bottom, residue number vs. RMSD (Å) plot of the same data in the top 
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residues in Eco tRNAQ required for correct Eco QRS recognition are found at the 
discriminator base (N73), the acceptor stem (N1:N72, N2:N71, and N3:N70), in the D 
arm stem (N10:N25, not detailed in Figure 5), and throughout the anticodon loop (N34, 
N35, N36, etc.).  Figure 5 details the spatial orientation of the anticodon and the acceptor 
stem relative to protein.  Other bases are known to contribute to proper recognition, just 
not at the level of those mentioned above. 
 
 
 
 
 
Figure 5. The ribonucleoprotein Eco tRNAQ2 bound to QRS (PDB id 1QTQ) 
top-left, N- and C-termini (red and green, respectively), as viewed looking down the T- and acceptor-stems 
top-right, acceptor stem; first three base pairs are colored red, discriminator blue, and the CCA tail cyan 
bottom-right, additional detail of acceptor end, illustrating discriminator base stacking with C75 and A76 
bottom-left, anticodon; C34, U35, and G36 (cyan, orange, and red, respectively) 
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v. Sce QRS 
 
 Like all Eukarya, the genome of Saccharomyces cerevisiae (Sce) contains a 
coding sequence for QRS, located within its GLN4 gene.26  While the C-terminal 595 
residues of the gene product contain the common features of a class I aaRS, there is also a 
224 residue N-terminal extension that is absent in Bacteria, including Eco (Figure S1).  
This domain appendage is present in most Eukarya, especially through Opisthokonta, but 
the exact role of this appendage is poorly understood. 
 Recently, two separate partial structures of Sce QRS were solved.  The most 
recent27 is of the C-terminal, catalytically active (residues 215-809) portion of the 
molecule and contains the same overall domain architecture as found in Eco QRS, 
expected given significant fold and ~38% sequence identity of the catalytic cores (Figure 
6).  Beyond the addition of the N-terminal domain, two insertions are found in residues 
364-368 (within the ASB) & 751-770 (within the ACB), the former of which appears to 
be a putative zinc binding motif specific to Ascomycota. 
 Previously, the N-terminal appendage was crystallized (residues 1-187).28  The 
first half of the Rossmann fold is preceded (progressing towards the N-terminus) by a 
flexible linker connecting to a four-coil helix-turn-helix subdomain bundle, followed by 
another flexible linker leading to a separate seven-coil helix-turn-helix subdomain bundle 
(Figure 6).  The C-terminal four helix subdomain demonstrated significant fold similarity 
when structurally compared to the tail domains of the GatB subunits of the 
Staphylococcus aureus and Thermotoga maritima amidotransferases despite low 
sequence identity. Additionally, the electrostatic potential surface calculated from the 
QRS NTD structure implies a co-localized positively charged partial surface suitable for 
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nucleic acid binding.  This arises in part from two clusters of lysine residues near the N-
terminal end of the NTD (residues 19, 20, 28, and 29) and near the C-terminal end of the 
NTD (residues 188, 189, 190, 196, 197, and 198). 
 
 
 
 
 
Figure 6. Domain expansion in Sce QRS, as illustrated in the partial crystal structures of 
the C-terminal catalytic core (residues 215 to 809; PDB 4H3S) & the helical N-terminal 
appendage (residues 1 to 187; PDB 3TL4) 
 
top-center, crystal structure of the Sce QRS C-terminal catalytic core, oriented & domain color-coded 
analogously to Eco QRS (see Figure 3); tRNA would bind on the left side of the enzyme 
top-right, detail of the two Sce QRS insertions (relative to Eco QRS), slight rotation to the left 
top-left, detail of the resolved N-terminal (red) & C-terminal (green) residues, slight rotation to the right 
bottom-left, crystal structure of the Sce QRS N-terminal appendage, with detail of the resolved N-terminal 
(red) & C-terminal (green) residues 
bottom-right, 180° rotation from left, illustration of the two helical bundles (ochre, green) connected by a 
flexible linker (red, dark space) 
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 In the same study28, the role of the NTD in Sce QRS was examined via steady 
state kinetic analysis (see lower sections of Tables 2 and 3) and in vivo viability 
screenings.  Mutant yeast cells expressing only an N-terminal domain (NTD) deletion 
mutant of Sce QRS (∆NTD-QRS, residues 211-809) exhibited slower growth at lower 
temperatures and increased susceptibility to L-methionine sulfoximine, a glutamine 
synthase inhibitor.  However, the mutant cell lines remained viable, and at higher culture 
temperatures (30°C), growth rates were comparable to cell lines expressing full length 
QRS in the same genetic construct, implying that the domain is dispensable.  The kinetics 
demonstrate that the NTD has little effect on catalytic rate (kcat), but KM values for tRNA 
and glutamine are significantly increased, with the tRNA KM value being the more 
greatly perturbed. Additionally, mutations were introduced into the NTD.  Alignments of 
eukaryotic QRS NTD appendages demonstrate little sequence identity.  However, some 
well conserved residues are present; these are located in a disordered flexible linker 
region between the N-terminal seven-helix subdomain and the C-terminal four-helix 
domain.  The mutant G112P (located in the flexible linker) was also examined with 
steady state analysis, yielding a 10-fold increase in KM for tRNA and a doubling of kcat 
(see Tables 2 and 3, Results & Discussion).  This mutant, in addition to three more 
mutant constructs (G112A/V113A/G114A, W160F, and W160A) all exhibited decreased 
tRNA binding as evidenced by electrophoretic mobility shifts in the presence of varied 
amounts of protein.  None of these mutants exhibited loss of tRNA binding capacity at 
the level of the ∆NTD Sce QRS variant. 
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vi. Eco tRNAQ2 vs. Sce tRNAQ2 vs. Sce mitochondrial tRNAQ1 
 
 tRNA identity elements are not always conserved across species.  This could be 
due in part to evolutionary pressure on tRNA sequence/structure brought on by 
divergence of their corresponding aaRSs, perhaps via the emergence of new domains 
mediated by aaRSs adopting novel non-canonical function within (and without) the cell.  
Comparison of the Eco & Sce tRNAQ2 cloverleaf representations (Figure 7) illustrate 
changes in a number of tRNA identity elements important for recognition by Eco QRS.  
Trans-kingdom identity shifts at the discriminator base and in the acceptor stem (Eco to 
Sce: G73U, U1G/A72C, and G3U/C70A) should be sufficient to preclude appreciable 
activity of Eco QRS upon Sce tRNAQ2 (see Tables 4 and 5, Results & Discussion).24,29,30  
However, the G10:C25 identity is conserved between the nuclear Sce and Eco tRNAs, as 
are the seven (unmodified) bases of the anticodon loop.  Sce mitochondrial tRNAQ1 (mt-
tRNA) has a number of commonalities and deviations relative to , perhaps most notably 
at the discriminator base (A73). 
 
 
 
 
Figure 7.31  Eco (left) and Sce (middle) tRNAQ2 sequences, compared to Sce mt-tRNAQ1 
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 Accordingly, Eco QRS is incapable of charging bulk Sce tRNA, nor is Sce QRS 
(as present in cell extract) able to charge bulk Eco tRNA.32 A hybrid construct of Eco 
QRS with the NTD of Sce QRS appended to its N-terminus is able to rescue GLN4 
deficient mutants constitutively expressing the hybrid product via a secondary gene.  The 
authors of this study indicate that the hybrid Eco QRS exhibited some lack of specificity 
in Sce bulk tRNA (cross charging was reportedly observed for Sce tRNAK & tRNAE), but 
appeared to retain specificity for tRNAQ as found in bulk Eco tRNA.  Furthermore, the 
authors indicated that the Eco QRS NTD hybrid construct continued to exhibit 
"preference" for Eco tRNA, as evinced by faster aminoacylation rates compared to bulk 
Sce tRNA. 
 A subsequent study from the same group33 examined which residue subset of the 
NTD was responsible for the trans-kingdom rescue.  This was achieved by way of similar 
in vivo experiments where several truncations of the Sce QRS NTD was appended to Eco 
QRS.  The results demonstrated that Eco QRS appended with Sce NTD residues 1-228 
(full length), 1-179, and 43-228 were able to rescue Sce QRS knockout alleles.  However, 
similar appendage of Sce NTD residues 1-42, 180-228, 1-106, and 43-179 were not 
sufficient to rescues these knockout strains; appendage of residues 107-228 yielded 
cultures with extreme growth retardation.  In the same study, an array of double and 
double-double alanine mutations were introduced into the lysine rich regions of the NTD 
and demonstrated that none of these residues alone are able to attenuate aminoacylation 
beyond detectable levels.  However, some of the double-double mutants demonstrated no 
activity, but only when one set of double mutants was in the N-terminal NTD helical 
bundle and the other set was in the C-terminal NTD helical bundle.  It has also been 
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reported34 that the Sce QRS NTD alone (residues 1-228) binds yeast tRNAs, a viral 
pseudoknot, and a single-stranded poly-A 35-mer with roughly similar affinity, implying 
that the NTD non-specifically binds double- and single-stranded nucleic acids, seemingly 
regardless of 3° fold. 
 The Sce protein Arc1p (i.e. GU4 nucleic-binding protein 1, G4p1) shares 
approximately 27% identity with the Hsa MARS scaffold protein AIMP1 and, like the 
eukaryotic QRS NTD, contains putative nucleic acid binding motifs.  The protein also 
serves as scaffold in the association of Sce MRS and ERS into a three membered 
complex reminiscent of the MARS complex observed in "higher" Eukarya.  It also 
appears to enhance binding of cognate tRNA isoacceptors for both aaRS members of this 
complex.35  The association appears to occur via folds (in all members) similar to 
glutathione S-transferase (GST), resulting in GST dimerization interfaces, a common 
protein-protein binding mode.36  Arc1p has also been implicated in preferential binding 
of G4 quadruplexes.37  Additionally, fusion of Sce Arc1p to Eco QRS, like the chimeric 
NTDSce-QRS, is able to rescue QRS knockout yeast strains upon supplementation in vivo 
and also demonstrates a marked increase in the rate of aminoacylation of Sce tRNA 
relative to WT Eco QRS in vitro.34  Furthermore, fusion of the (unrelated) eukaryotic 
nonspecific nucleic acid binding N-terminal appendage of Sce or Hsa valyl-tRNA 
synthetase (VRS) to Eco QRS also rescued QRS knockout yeast strains.38  Interestingly, 
the native Sce QRS exhibited varied binding affinities to a mixed tRNA population, 
whereas the two N-terminal appended Eco QRS constructs appeared to bind across the 
population more or less equivalently.  Finally, another group demonstrated31 that Eco 
QRS N-terminally fused with Arc1p is able to rescue the indirect Sce mitochondrial 
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glutaminyl-tRNAQ synthesis pathway in vivo (via mitochondrial amidotransferase 
knockout alleles) and exhibited significant aminoacylation towards mt-tRNAQ1, whereas 
the WT Eco and Sce did not. 
 
 
vii. unknown molecular recognition, direct or otherwise? 
 
 The functional role of domain appendages for many aaRSs have been studied, and 
in many cases within Hsa those appended domains serve regulatory roles separate from 
canonical aminoacylation activity.8  Prior work39,40 with other domain-appended aaRSs 
establishes precedent for more closely examining the role of the N-terminal appendage as 
found within Sce QRS, perhaps in its primitive form.  Additionally, molecular dynamics 
simulations of modeled full length Sce QRS (3TL4 and 4H3S), in part based on solution 
small angle X-ray scattering, suggest dynamics previously not observed in QRS 
systems.27  Specifically, the NTD was predicted to potentially make contacts with the 
catalytic core.  Additionally, the simulation predicts distortion of tRNA upon NTD 
binding, compelling U73 of tRNAQ2 to flip inwards toward enzyme, potentially making 
meaningful contacts with Leu463. 
 Herein is described a study investigating what, if any, influence trans-kingdom 
isoacceptor tRNA identity element shifts have regarding the N-terminal extension of Sce 
QRS.  This is achieved via steady state analysis of Sce tRNAQ2 species mutated at the 
discriminator base, the acceptor stem, and the anticodon.  Additionally, the nature of the 
N-terminal extension is briefly considered, with discussion focused on Hsa. 
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2. EXPERIMENTAL 
 
 
i. protein 
 
 Full length Sce QRS (residues 1-809), provided by labmate Andrew Hadd, were 
expressed and purified as previously described.28  Protein was stored at -20 °C in 20 mM 
Tris-HCl (pH 7.5), 200 mM NaCl, 5 mM β-mercaptoethanol (β-ME), and 50% (v/v) 
glycerol. 
 
 
ii. DNA template synthesis via Klenow fragment 
 
 tRNA was enzymatically synthesized via chemically synthesized DNA oligomers, 
principally via adoption of the methods previously described.41  In summary, a DNA 
oligomer corresponding to the tRNA gene, with bacteriophage T7 RNA polymerase 
promoter and TATA binding box appended upstream of tRNA sequence, is synthesized 
via Klenow fragment utilizing two DNA oligomer templates, one corresponding to 
roughly half of the 5′ forward sequence and the other corresponding to the first 5′ half of 
the sequence reverse complement, such that there is an approximately ten base pair 
overlap to ensure cross-primer hybridization.  Additionally, the two terminal 5′ residues 
of the reverse complement DNA template are 2′ O-methylated to ensure product tRNA 3′ 
homogeneity.  Transfer RNA is then produced via T7 transcription of the ~100 base pair 
DNA product.  Mutation of Sce tRNAQ2 sequence was achieved by altering the design of 
the DNA templates at the appropriate position.  Specific DNA oligomer sequences are 
detailed in Appendix B. 
 Specifically, Klenow reaction was performed at equimolar DNA template 
concentrations (4 µM), 10 units of Klenow fragment (Thermo Scientific), 10 mM each 
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dNTPs, and the manufacturer supplied enzyme buffer stock at the appropriate dilution.  
Normally, reactions were executed at 2 nmol scale (500 µL reaction volume).  Reaction 
was effected via PCR block with the following program: hold at 10 °C for 45 seconds, 
ramp up to 37 °C at 0.2 °C/sec, hold for 45 seconds, ramp down to 10 °C at 0.2 °C/sec, 
and repeat 15 cycles.  Upon program completion, the block is held indefinitely at 4 °C.  
Lid temperature was constant at 100 °C.  DNA was then precipitated by diluting 1:1 (v/v)  
with ethanol and adding sufficient sodium acetate and acetic acid to bring their 
concentrations to ~300 mM and ~200 mM, respectively.  This solution was then placed in 
the freezer at -20 °C at least overnight.  Before use, Klenow product is spun at 14000 
RPM for 30 minutes to pellet DNA.  Supernatant is removed, the pellet is washed with 
80% (v/v) cold ethanol, and re-pelleted at 15000 CFG for 10 minutes.  Supernatant is 
removed again, the pellet is dried under vacuum centrifugation for ~10 minutes, and 
resuspended in 18 MΩ water filtered through .22 µm PES syringe filter (VWR).  Product 
is verified on 2% (w/v) agarose gel against 100 base pair DNA ladder (Figure S2).  As no 
evidence of DNA oligomer template primers is observed in these gel analyses, reaction is 
assumed to have progressed to completion.  As such, each normal scale reaction yields 
approximately 1 nmol of DNA duplex template. 
 
 
iii. tRNA synthesis and purification 
 
 T7 transcription reaction was carried out with half (~0.5 nmol) of the Klenow-
produced DNA template product in solution containing 40 mM Tris-HCl (pH 8.0), 25 
mM MgCl2, 2 µM spermidine, 0.01% (v/v) Triton X-100, 40 mM dithiothreitol (DTT), 4 
mM each Mg:rNTPs, 10 µL containing 0.01 mg of yeast PPiase (Roche), and 200 µL T7 
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RNA polymerase (5.99 mg/mL, Perona lab stock; strain 87) per 4 mL reaction.  After 
reaction overnight at 37 °C, the product tRNA is recovered from the upper 
phenolic/aqueous layer upon addition of an equal volume of biphasic extraction mixture: 
25:24:1 phenol:chloroform:isoamyl-alcohol, pH 4.1 (Sigma).  Care was taken to ensure 
crashed salts and protein at the biphasic interface weren't aspirated along with upper 
layer.  A second extraction was then carried out on the first aqueous layer in the exact 
same fashion.  The second extract was concentrated to ~250-500 µL via 10 kDa 
molecular weight cutoff (MWCO) ultracentrifugation device (EMD Millipore), mixed 
1:1 (v/v) with 2x RNA loading dye {15% (v/v) formamide, 5 mM EDTA (pH 8.0), 
0.025% w/v sodium dodecyl sulfate, bromophenol blue, and xylene cyanol}, and loaded 
onto a 250 mL 10% (v/v) 19:1 acylamide:bisacrylamide 7 M urea-PAGE preparatory gel 
pre-run for 30 minutes at 30 Watts in Tris-HCl/boric acid/EDTA (TBE) running buffer. 
 Separation is achieved by running at 50 Watts for approximately 4 hours.  tRNA 
is identified by UV shadow (Figure S3) and excised from bulk gel using a sterilized 
scalpel.  The tRNA containing gel piece is then placed in a falcon tube, crushed, and 
submerged with extraction solution of 10 mM Tris-HCl (pH 8.0), 1 mM EDTA (TE).  
After shaking overnight at room temperature, extraction solution is recovered and filtered 
through 0.45 µm PES syringe filter (VWR) followed by a second filtration through 0.22 
µm PES syringe filter (VWR).  The filtrate is concentrated with 10 kDa MWCO 
ultracentrifugation device (EMD Millipore), followed by several buffer exchanges with 
TE in 3 kDa MWCO microfuge ultracentrifugation device (EMD Millipore). 
 The tRNA is subsequently precipitated, pelleted, dried, and reconstituted into TE 
solution using the same procedure as described for the DNA template Klenow product in 
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the preceding section.  Concentration determination was achieved by measuring UV 
absorption at 260 nm, utilizing the molar absorptivity coefficient (ε260 nm) calculated by 
OligoCalc (http://www.basic.northwestern.edu/biotools/oligocalc.html),42 as based upon 
mutant sequence input.  The ratio A260/A280 was always >2.  Fidelity of product was 
ascertained by analytical urea-PAGE separation, visualized with toluidine staining, and 
compared to another co-run tRNA, typically Eco tRNAQ2 (Figure S4).  Yields of purified 
tRNA were typically 0.5 to 1.0 mg (~20 to 40 nmol) per 0.5 nmol DNA template. 
 
 
iv. 32P labeling of tRNA 
 
 Incorporating 32P radionuclide into the 5′ internucleotide linkage between the 3′ 
terminal A76 and C75 (N-1) is achieved by the Eco CCA-adding nucleotidyltransferase 
in the presence of [α-32P] rATP, as previously described.21  The labeling reaction is 
carried out in 25 mM HEPES (pH 7.4), 6.25 mM MgCl2, 0.3125 mM DTT, 2 µM tRNA, 
2.5 mM PPi, 5 µL [α-32P] rATP (PerkinElmer) at 3000 Ci/mmol (or, 10 mCi/mL, per 
assay date), and 6 µL CCA enzyme (5.99 mg/mL, Perona lab stock, strain 26) per 80 µL.  
Reactions are typically at a total volume of 80 µL and executed at 37 °C. 
 Before reaction, tRNA is refolded by heating tRNA stock and water to 80 °C for 
three minutes, transferred to 65 °C for five minutes, the magnesium containing CCA 
buffer (also at 65 °C) is added, then the metal block is removed from the heat plate and 
allowed to slow cool on the bench.  PPi and [α-32P] rATP are added once folded tRNA 
has cooled to 37 °C; reaction is then initiated by addition of CCA enzyme.  The reaction 
is allowed to proceed for one minute, and 2 µL containing 0.002 mg of yeast PPiase 
(Roche) is added and allowed to incubate for another four minutes at 37 °C.  Reaction is 
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terminated by addition of 25:24:1 phenol:chloroform:isoamyl-alcohol, pH 4.1 (Sigma).  
After recovery of the phenol-aqueous layer (top) followed by second biphasic extraction, 
labeled tRNA is purified and concentrated as with T7 transcripts.  Purification was 
achieved via 55 mL purification gel (~11% (v/v) 29:1 acylamide:bisacrylamide), 
containing no urea.  Visualization of labeled tRNA is achieved by brief exposure of gel to 
phosphor storage screen, printing out 1:1 scale to use as guide (Figure S5).  Labeled 
tRNA is then extracted overnight at 4 °C with TE buffer (in the same fashion described 
above for T7 transcript purification), filtered through a 0.45 µm PES centrifugal filter, 
buffer exchanged, ethanol precipitated, vacuum dried, reconstituted in TE buffer, stored 
in aliquots at -20 °C, and used within two weeks.  As the radionuclide is located at the 
internucleotide linkage between the unpaired 3′ terminal A76 and C75 residues, damage 
due to ionizing radiation should be readily visualized by TLC due to potential for 
liberation of mono- and di-nucleotides.  Fidelity was estimated with every set of assays 
by spotting undigested 32P labeled tRNA (directly from freezer stock and after folding) 
onto PEI and running in parallel to digested assay time points. 
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v. steady state aminoacylation assay 
 
 Steady state assay was adopted from a previously described method,21  and were 
performed per Scheme 2. 
 
 
N
N
N
N
NH2
O
OO
HH
HH
PO
O-
OH
A76
QRS
Gln
rATP
Gln
Nuclease P1
H2O
c75
c74
HO
O-
32PO
O-
O
N
N
N
N
NH
2
O
OOH
HH
HH
A76
Gln
O-
32PO
O-
O
N
NH
2
ON
O
OHO
HH
HH
PO
O-
O
N
NH
2
ON
O
OHO
HH
HH
PO
O-
O
C75
C74
N
N
N
N
NH
2
O
OHOH
HH
HH
A76O-
32PO
O
O
PPi
rAMP
c75
c74
 
 
Scheme 2. tRNAQ2 charging and nucleolytic liberation of modified 32P labeled nucleoside 
 
 
 All reactions were executed at 37 °C in 50 mM Tris-HCl (pH 7.48 at 37 °C), 10 
mM MgCl2, 10 mM β-ME, and 5 mM Mg:rATP.  Reaction volume was 20 µL in all 
cases.  Glutamine and rATP freezer stocks were brought to pH ~7 by addition of 1 M 
Tris-HCl and 50% (w/v) NaOH, respectively.  Glutamine concentrations were varied 
from 0.1 to 60 mM for KMQ measurements.  tRNA concentrations were varied from 0.02 
to 40 µM for KMtRNA determinations.  Trace 32P labeled tRNA was volumetrically 
constant in all time courses at 1 µL freezer stock per 20 µL reaction.  Substrate saturation 
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was ensured for glutamine and tRNA (Figures S6, S7), but was assumed for rATP.  
Enzyme concentrations remained constant within each set of substrate range time 
courses, but were suitably varied to accommodate tRNA mutants.  As such, QRS 
concentrations were varied from 1 nM to 100 nM, but the ratio of tRNA:QRS was 
maintained above 20:1, ensuring that measurements were within the multiple turnover 
regime.  All tRNAs were refolded prior to assay as described for the CCA labeling 
reaction and left at room temperature just prior to use. 
 After reactions were initiated in individual time courses by addition of 10 µL of 
2x tRNA solution to 10 µL of 2x {QRS, Glutamine, rATP}.  Both solutions contained 
equal concentrations of the remaining buffer components.  Aliquots (2 µL) were taken 
every 10 seconds and diluted five fold into 8 µL of solution containing 400 mM sodium 
acetate (pH 5.2) with 0.25 units nuclease P1 (Sigma-Aldrich) to quench the reaction and 
digest tRNA.  Subsequently, one µL of this solution was spotted onto scored pre-run 
polyethyleneimine (PEI) cellulose plates and developed with solution containing 400 mM 
ammonium acetate with 5% (v/v) acetic acid to separate pA76-Gln and pA76-OH, 
corresponding to reacted and unreacted tRNA respectively.  Plates were dried, wrapped 
in plastic wrap, and exposed overnight to phosphor screen.  The exposed phosphor screen 
was then scanned using Typhoon scanner (GE Healthcare Life Sciences) and spot 
intensities were quantitated using ImageQuant (GE Healthcare Life Sciences).  The ratios 
of pA76-Gln to unreacted pA76-OH can then be used to calculate moles of product 
formed.  Individual time course initial rates are determined via linear regression analysis, 
as included with Excel (Microsoft); only aminoacylation values corresponding to less 
than 20% total reacted tRNA substrate were used.  Non-linear fitting of initial rate time 
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courses to the Michaelis-Menten equation were achieved via KaleidaGraph (Synergy 
Software), yielding the Michaelis-Menten constant (KM) and maximal velocity (Vmax), 
which in turn yield kcat, given enzyme concentration.  Initial estimates for the fits were 
estimated by visual inspection of plotted data; maximum allowable error was defined at 
0.1%, per KaleidaGraph dialogue entry.  MM plots can be found in Appendix C.  Raw 
data for reported values and FASTA files can be found in Appendix D. 
 
vi. alignments (sequence- & structure-based), visualizations, data mining, and 
association networks 
 
 Multiple sequence alignments were performed in the Visual Molecular Dynamics 
(VMD) environment via the MultiSeq43 plug-in.  Protein sequence based alignments were 
performed with CLUSTAL-W.44  Structure based alignment was achieved using the 
STAMP45 algorithm.  All structures used were obtained from either the RCSB PDB 
(http://www.rcsb.org) or from the Protein Data Bank in Europe 
(http://www.ebi.ac.uk/pdbe).  All sequences used came from the UniProtKB 
(http://www.uniprot.org/help/uniprotkb).  Homology models were constructed on 
UniProtKB reviewed entries using the SWISS-MODEL web server 
(http://swissmodel.expasy.org).   All tRNA sequences were obtained from the UCSC 
tRNAdb46 (http://gtrnadb.ucsc.edu), and tRNA alignments were the product of the 
deposited COVE alignments of the predicted gene products located on that site. 
 Protein-protein associations were predicted by STRING v9.147 (http://string-
db.org) by the multiple names search mode at the default (0.400) confidence level.  For 
Hsa results, the genes QARS and AIMP1 were the input; results for coexpression, 
textmining, and neighborhood were excluded for the sake of clarity.  For Sce results, the 
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genes GLN4 and ARC1 were used as input; results for coexpression and textmining were 
excluded.  Additional protein-protein interaction predictions were provided by 
BioGRID48 v3.2.114 (http://thebiogrid.org) using the input QARS and GLN4 for Hsa and 
Sce, respectively.  Intrinsic disorder predictions were provided via the 
DISOPRED3/DISOPRED2 algorithm provided by the PSIPRED Protein Sequence 
Analysis Workbench49 (http://bioinf.cs.ucl.ac.uk/psipred) webserver using the canonical 
FASTA sequences for Hsa QRS (full length: 1-775; NTD: 1-225) and Sce QRS (NTD: 1-
228) were used as input. 
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3. RESULTS & DISCUSSION 
 
i. does the Sce QRS NTD influence tRNA recognition? 
 
 To ascertain the extent of influence the QRS NTD has in relation to tRNAQ 
identity elements, eight mutant Sce tRNAQ2 species were constructed, of which five were 
subjected to steady state analysis.  Wild type glutamine-based measurements were 
performed for internal comparison (Figures S8 and S9).  Mutations were introduced in 
the acceptor stem, the anticodon loop, the D-stem, and at the discriminator base (N73).  
Table 1 lists the homologous tRNAQx bases for Eco and Hsa as compared to Sce; 
mutations introduced into Sce tRNAQ2 are included in the same table. 
 
 
 Table 1.  tRNAQ2 consensus nucleotides & mutant Sce tRNAQ2 species used in this study 
 
 
 Between Eco and Sce, major identity shifts are evident at the discriminator base 
(N73) and within the acceptor arm (N1:N72 and N3:N70).  The remaining major identity 
elements are in consensus.  Of note is the Eco U1:A72 pair (compare to G1:C72 in Sce), 
as the majority of Eco tRNA utilize a G1:C72 pair at this position. Additionally, 
structural evidence19 and kinetic analysis24,30(partially depicted in Table 4) implicate this 
identity as one of the major determinants for Eco QRS selecting against tRNAE.  
Specifically, Leu136, located within CP1, appears to be involved in disrupting the base 
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pairing between U1 and A72, such that the 3′-terminal GCCAOH (N73-N76) is free to 
form a hairpin back upon itself, as observed in the active site (Figure 5). 
 Eco tRNAQ2 G73 is homologous to Sce tRNAQ2 U73.  Substitution of tRNAQ2 
G73 to U73 in Eco has been shown24 to have a pronounced detriment upon tRNA 
"specificity" (kcat/KM) comparable to mutations within the anticodon (see Table 5).  
Another study, utilizing glutamine-varied steady state analysis,24also demonstrated the 
ability of this mutant to have significant effect on specificity (see Table 4).  The other 
two possible mutations of Eco G73 to either A or C also had significant effect. 
 Steady state parameters for five Sce tRNAQ2 mutants (U73A, U73G, U73C, 
G1U/C72A, and G36C) were determined as described and are presented in Tables 2 and 
3. 
  Table 2.  Steady state parameters for glutamine, compared to literature values 
 
 
 
 
  Table 3.  Steady state parameters for tRNA, compared to literature values 
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For the purpose of discussion, WT Sce tRNAQ2 experimental and literature28 kcat/KM 
discrepancies were assumed to be similar for tRNA- and glutamine-derived value sets 
(note that ratio (kcat/KM)exp/( kcat/KM)lit is greater than one, Table 2, right column).  Of 
interest, the kcat values for U73A and U73G were greater than WT; the remaining mutants 
(U73C, G1U/C72A, and G36C) exhibited rate reductions of about 10-fold.  All observed 
mutant KM values were elevated relative to WT.  Steady state analyses with tRNA were 
not performed on WT or G36C, due to time constraints.  As such, only comparison to 
tRNA-derived values of WT tRNAQ2 from the literature28 are provided for comparison 
with this dataset.  All measurements were performed in triplicate, with the exceptions of 
U73G and U73C, which were measured in duplicate. 
 Comparison of this data with similar mutational studies24,30 in Eco tRNAQ2 is 
found in Tables 4 and 5 for glutamine- and tRNA-derived parameters, respectively.  
Inspection indicates that both systems tolerate N73A mutants better N73C mutants.  
Additionally, both systems exhibit an elevation in kcat with N73A mutants.  Increases in 
KM compensate for this, resulting in lowered specificity, more pronouncedly in specificity 
comparisons derived from tRNA measurements.  However, it should be noted that the 
tRNA derived values for Eco30 may have been determined from assay conditions in 
which glutamine was not at saturating concentrations, as 14C labeled glutamine substrate 
was employed at 0.1 mM, well below the glutamine KM values subsequently reported.24  
N73C mutants were detrimental in both systems, but relatively more tolerated by Sce 
QRS, at least in glutamine-based measurements.  Mutating Sce tRNAQ2 at the 
discriminator base to the consensus Eco tRNAQ2 N73 (U73G) negatively impacted 
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specificity via increases in KMQ and KMtRNA; observed kcat values were comparable or 
faster (as with glutamine values). 
 
 Table 4.  Steady state parameters for Gln, compared to Eco24 QRS with Eco tRNAQ2 mutants 
 
 
 
 
 Table 5. Steady state parameters for tRNA, compared to Eco30 QRS with Eco tRNAQ2 mutants 
 
 
 
 
 Sce tRNAQ2-G36C proved to be the poorest substrate out of the mutants tested.  
Unaware of any previous G36C cognate tRNA measurements in Eco, comparisons had to 
be made with other mutants at the same position. Not surprisingly, the Eco system 
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apparently strongly discriminates against mutations at this position, especially against 
G36A; G36U is also a very poor substrate for Eco QRS.  Subsequent work21 with Eco 
tRNAQ2-G36U reaffirms this trend with constants determined under substrate saturation.  
Finally, the Sce tRNAQ2-G1U/C72A double mutant exhibited pronounced decreases in 
kcat/KM in both tRNA and glutamine measurements, as shown by elevations in both kcat 
and KMQ. 
 It has been suggested50 that the presence of a pyrimidine following either G1:C72 
or C1:G72 in tRNA has a destabilizing effect on the base pair, lowering the energy 
required to disrupt WC geometry (or perhaps promote subsequent stacking interactions?).  
Most Eco tRNAs have a G1:C72 base pair in tRNAQ2, as does Sce tRNAQ2.  Unlike Eco 
tRNAQ2, Sce tRNAQ2 contains U73, a pyrimidine, perhaps to assist the protein in 
destabilizing the N1:N72 base pair.  However, U73C is a poor substrate.  This could yet 
be due to unknown protein:RNA, intra-RNA:RNA (protein mediated?), and/or 
protein:protein (tRNA mediated?) interactions within the system. 
 There has been suggestion28 that the shift to U73 in Eukaryotic tRNAQx is linked 
to adoption of the N-terminal QRS appendage.  The data presented here support that U73 
is indeed preferred by Sce QRS, but as to whether this is a consequence of evolutionary 
mutation across the older, more conserved "core" protein, or due to interactions of the 
NTD with the tRNA core and/or the core protein, remains elusive.  It is not known for 
certain whether analogous decoupling even occurs in the Sce QRS system.  Revisiting 
these mutants with a mutant Sce QRS lacking its N-terminal domain appendage (∆NTD-
QRS) would potentially provide insight into intra-complex signaling if different trends in 
kcat/KM were observed.  Additionally, similar kinetic comparisons of WT Sce QRS to 
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∆NTD-QRS with additional tRNAQ2 mutants, such as RNA microhelices or deletion 
mutants in the 5′ stand of the acceptor stem (i.e. ∆N1 to assess importance of N72 
identity independent of decoupling).  Additional point mutations across the "elbow" of 
the 3° fold of the tRNA, especially those that would introduce little perturbation to the 
stacking core but potentially in proximity to the NTD, could possibly uncover additional 
identity elements. 
 If anything, it would appear that the Sce system is more relaxed with regards to 
discriminator identity (Tables 4 and 5).  Averaging the relative (kcat/KM)mutant/( kcat/KM)WT 
glutamine-derived values for the three discriminator mutants yields a crude composite 
kcat/KM relative to WT of 28.3% vs. 22.3% for Sce and Eco, respectively.  As tRNA-
derived steady state values were not determined in this study, comparison with WT 
literature kcat/KM must be made.  The WT-tRNAQ2 glutamine-derived constants presented 
herein exhibit a (kcat/KM)exp/(kcat/KM)WT_lit ratio of 190.8%.  Similarly, the glutamine-
derived U73A (kcat/KM)exp/(kcat/KM)WT_lit ratio is 121.5%, but the 
(kcat/KM)exp/(kcat/KM)WT_exp ratio is 63.7%.  Assuming (kcat/KM)exp/(kcat/KM)WT_lit and 
(kcat/KM)exp/(kcat/KM)WT_exp (the latter of which wasn't determined) discrepancy is similar 
for tRNA-derived constants, the values in Table 5 (right-most column) can be scaled 
accordingly.  The corrected average of (kcat/KM)mutant/( kcat/KM)WT_lit for the Sce tRNAQ2 
discriminator mutants thus becomes 23.7% compared to an Eco average of 16.9%.  
Without discrepancy scaling, the Sce tRNAQ2 mutants yield an average 
(kcat/KM)exp/(kcat/KM)WT_lit of 45.3%. 
 In light of the fact that Hsa tRNAQx sequences are quite promiscuous (Table 1, 
Figures S11 and S12) with consensus identities, this seems reasonable, as Hsa QRS has 
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also adopted the eukaryotic N-terminal appendage.  Across the three principal species 
discussed in this document (Eco, Sce, and Hsa), tRNA containing C73 is only known to 
exist in Eco tRNAH, Sce tRNAP, and Hsa tRNAP species, in addition to few others in Hsa 
(Figures S11 and S12): 2x tRNAQ (chr3.tRNA9, chr6.tRNA131), 1x tRNAL 
(chr10.tRNA3), 1x tRNAF (chr6.tRNA112), and 1x tRNAW (chr9.tRNA3).  As to 
whether all, or any, of these gene products are utilized for translation is entirely 
unknown. 
 Hsa has an abundance of paralogous tRNA genes (see Introduction, section i), as 
predicted by the tRNAscan-SE51 analyses deposited in the UCSC Genomic tRNA 
Database46 (http://gtrnadb.ucsc.edu).  According to the most recently deposited analysis 
(hg19 - NCBI Build 37.1 Feb 2009), there are 506 "standard" tRNAs (putatively 
accepting one of the twenty canonical amino acids), three selenocysteine tRNAs, three 
possible suppressor tRNAs, three "tRNAs" with undetermined/unknown isotype(s), and 
110 predicted pseudogenes.  Excluding predicted pseudogenes (PG), this totals to 515 
genes that appear to code for putatively expressed tRNA (or tRNA-like) products.  By 
comparison, Eco (K12) encodes for 87 tRNA products (+1 PG) and Sce (S288c Apr 
2011) encodes 289 (+6 PG) tRNA products. 
 Additional sets are not necessarily indicative of "higher" evolution or complexity 
of organism; ploidicity may play a role as well.  The complement of genomic tRNA 
products varies wildly: Leishmania major (Version 5.0) encodes 82 (+1 PG), Drosophila 
melanogaster (Release 6 Apr 2006) encodes 300 (+4 PG), Felis catus (catChrV17e Dec 
2008) encodes 3095 (+0 PG), and Danio rerio (Zv9 Jul 2010) encodes 12844 (+0 PG).  
Of note among the species mentioned here, Hsa has a disproprionately high number of 
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predicted pseudogenes.  Brief examination of a few other deposited analyses from other 
simian species (chimp, gorilla, rhesus monkey, baboon, and orangutan) do not indicate 
the presence of any pseudogenes, but all encode for a similar number of tRNAs (~380-
470) relative to Hsa. 
 
 
ii. evolutionary repurposing? 
 
 The Search Tool for the Retrieval of Interacting Genes (STRING)47 meta-
analysis webserver parses the information from a number of principal databases47,52–55 in 
addition to the information stored in numerous other databases, including known 
associations (MINT,56 KEGG,57 etc.), text mining on PubMed, and predictive methods.  
In doing so, a network of protein-protein association predictions is generated, with color-
coded links between partner nodes representing the data type used for prediction.  The 
default search includes results related to genomic context, high throughput, conserved 
expression, and textmining.  All associations are assigned a confidence score; the 
mathematical details of which can be found within the appropriate reference.  A 
conservative results-limited query (excluding coexpression and textmining associations) 
on the STRING webserver for the Sce genes GLN4 (GLN4p = QRS) and Arc1 (Arc1p is 
the yeast orthologue of AIMP1, a MARS scaffold protein) compared to a similar search 
for the Hsa genes QARS (additionally excluding "neighborhood" results as well, for 
simplicity) and AIMP1 suggest the nature of interconnectivity between the members of 
MARS and how they potentially relate to diverse cellular functions (Figure 7, Appendix 
D).  A search against Hsa QARS alone with all associations enabled illustrates the 
complexity of results with textmining and coexpression associations (Figure S13).  Not 
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surprisingly, coexpression data produces a lot of noise, given that QRS is part of the 
translation apparatus and expression is certainly coregulated along with other 
translational and transcriptional proteins as a function of cell cycle, DNA damage, etc. 
  
 
    
 
Figure 8.  Comparison of Sce (left) and Hsa (right) QRS and Arc1p or AIMP1 associations, 
respectively, as predicted by STRING47 
 
genetic neighborhood (green), probable gene fusion events (red), cooccurrence (blue), 
conserved coexpression (black), high-throughput experiments (magenta), databases 
(cyan), textmining (green), and homology (mauve) 
 
 A different data mining webserver, The Biological General Repository for 
Interaction Datasets (BioGRID)48 is limited to experimental data (affinity capture, co-
fractionation, two-hybrid, etc.) and includes low-throughput studies.  A comparison of 
Sce GLN4 vs. Hsa QARS results (without altering any settings) also provides a stark 
depiction of the level of complexity arising in "higher" Eukarya (Figure 8, Appendix D).  
Certainly both of these servers are biased by the amount of data produced by high-
throughput experiments, and likely contain many false associations, due to both empirical 
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(i.e. database entries) and other incorrect hits.  However, there are many intriguing 
connections amongst the various nodes, hinting at countless unknown cellular subtleties. 
 
 
    
 
Figure 9.  Comparison of Sce (left) and Hsa (right) QRS associations as predicted by 
BioGRID48 
 
 Partial details regarding the nature of some of these interacting partners can be 
found in Table 6.  One of the entries, MAP3K5 (i.e. ASK1), had previously been 
implicated in glutamine-dependent interactions with Hsa QRS.58  In short, Hsa QRS 
appears to inhibit the kinase activity of ASK1 given sufficient cytoplasmic glutamine 
concentrations.  The same study also implicated that residues 237-775 (the catalytic core 
and ABD) of Hsa QRS were necessary for association with MAP3K5, potentially 
precluding the N-terminal domain extension in this interaction.  Also amongst the 
predicted STRING associations is TRAF2, another protein involved in cell cycle and 
apoptosis.  Additionally there are predicted associations with transcription factors  
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Table 6.  Further information on predicted association/interaction partners with Hsa QRS, as 
predicted by STRING (top) and BioGRID (bottom) 
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(GATA5 and ERCC3), a urea cycle protein (ASL), and a heat shock protein 
(HSP90AA1).  The entries D6S51, BAT2, and ENSG00000231825 may be redundant,  
isoforms, or erroneous database entries, as some (but not all) of the various accession 
numbers have been deleted on some of the databases.  The RSBN1 association is 
amongst the highest scoring, higher than even some of the MARS members, but is a 
protein of unknown function.  Examination of the BioGRID results exhibit similar 
diversity of nuclear and cytoplasmic interaction partners, including two viral proteins. 
 It has been proposed that the MARS complex begins in Arthropoda and is limited 
to Metazoa (i.e. "drosophila to humans") and is possibly linked with multicellularity and 
the development of more complex anatomies, including development,14 but examples of 
simpler complexes (in terms of number observed interaction partners) can be found 
throughout Opisthokonta.  The simplest example of a possible evolutionary MARS 
precursor analogue can be found in the Sce minimal multi-aaRS synthetase complex, 
which consists of ERS, MRS, and Arc1p, a homolog of the MARS scaffold protein 
AIMP1.  It has also been speculated that adoption of the eukaryotic N-terminal 
appendage is somehow co-evolutionarily related to the emergence of MARS and/or the 
recruitment of QRS into the complex.59   
 Putative protein-protein binding motifs in either the Sce or Hsa QRS N-terminal 
domains are not known, unlike in several of the other MARS-associated synthetases8.  
Additionally, Sce QRS is not known to be a member of the Sce ERS:MRS:Arc1p mini-
MARS assembly, but it possesses the extension nonetheless.  However, a prediction of 
intrinsic protein disorder (and protein-protein binding that that sometimes imparts) 
provided by PSIPRED predicts that residues ~175-225 could be involved in protein 
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binding (Figures S14 and S15).  Subjecting the NTD of Sce QRS to the same analysis 
provides similar results (Figure S16).  A pull-down study60 of an array of Myc epitope-
tagged Hsa QRS progressive deletion mutants transiently expressed in HEK 293 cell line 
demonstrate that residues 237-457 (corresponding to N-terminal portion of the catalytic 
core of the protein) were required for MARS association, albeit at the loss of endogenous 
(full-length) QRS, arginyl-tRNA synthetase (RRS), and AIMP1 from the complex.  It 
could be that the disordered residues interact with AIMP1 in a fashion such that it adopts 
the proper conformation required for binding with RRS and another of its interaction 
partners, AIMP2.  However, if the association is limited to the catalytic core, it would not 
be the first time the catalytically active domain of an Hsa protein has apparently adopted 
expanded function.61  Of interest, the non-canonical functions assigned to AIMP1 require 
its dissociation from the MARS complex.62 
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4. CONCLUSION 
 
 There is still much to be learned about the aaRSs and their interacting partners, 
the AIMPs.  The MARS interaction network has been studied,63 but at low resolution.  
Additionally, the MARS complex has been studied with cryo-EM,64,65 but not at the high 
resolution afforded by the newest generation of instrumentation.  Undoubtedly a chemical 
cross linking study coupled with tryptic digest and LC-MS/MS, similar to that performed 
on transcription initiation complexes,66 would provide a wealth of insight.  Similar 
analyses on "lower" Eukarya, such as Caenorhabditis elegans which has a MARS 
assembly of intermediate complexity,67 could aid in drug development by targeting the 
translation machinery in novel ways to defend against Trypanosomes and other 
problematic Eukaryotic parasites, known to have unique aaRS features and MARS like 
aspects.68–70
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Figure S3.  Purification gel, showing UV shadow 
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Figure S5.  Purification gel after 32P labeling of tRNA via Eco CCA nucleotidyl-
transferase 
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Figure S13.  Hsa QARS STRING association predictions 
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Figure S14.  Hsa QRS intrinsic disorder profile, as predicted by DISOPRED, 
residues 1-775 
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Figure S15.  Hsa QRS intrinsic disorder profile, as predicted by DISOPRED, 
residues 1-225 
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Figure S16.  Sce QRS intrinsic disorder profile, as predicted by DISOPRED, 
residues 1-228 
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APPENDIX B - DNA oligomers used in synthesis of Sce tRNAQ2 mutants 
 
 
WT sequence (without CCA) 
>Sce_chr13.trna8-GlnCTG (808316-808245) 72 bp  Sc: 64.54 
GGTCCTATAGTGTAGTGGTTATCACTTTCGGTTCTGATCCGAACAACCCCAGTTCGAATCCG
GGTGGGACCT 72 nt 
 
 
U73A 
Promoter & 3' CCA sequence appended; incorporate U73A mutation:  
AATTCCTGCAGTAATACGACTCACTATAGGTCCTATAGTGTAGTGGTTATCACTTTCGGTTC
TGATCCGAACAACCCCAGTTCGAATCCGGGTGGGACCACCA 103 nt 
 
Final Forward: 
AATTCCTGCAGTAATACGACTCACTATAGGTCCTATAGTGTAGTGGTTATCACTTTC 
Final Reverse: 
mUmGGTGGTCCCACCCGGATTCGAACTGGGGTTGTTCGGATCAGAACCGAAAGTGATAA 
 
 
U73G 
Promoter & 3' CCA sequence appended; incorporate U73G mutation:  
AATTCCTGCAGTAATACGACTCACTATAGGTCCTATAGTGTAGTGGTTATCACTTTCGGTTC
TGATCCGAACAACCCCAGTTCGAATCCGGGTGGGACCGCCA 103 nt 
 
Final Forward: 
AATTCCTGCAGTAATACGACTCACTATAGGTCCTATAGTGTAGTGGTTATCACTTTC 
Final Reverse: 
mUmGGCGGTCCCACCCGGATTCGAACTGGGGTTGTTCGGATCAGAACCGAAAGTGATAA 
 
 
U73C 
Promoter & 3' CCA sequence appended; incorporate U73C mutation:  
AATTCCTGCAGTAATACGACTCACTATAGGTCCTATAGTGTAGTGGTTATCACTTTCGGTTC
TGATCCGAACAACCCCAGTTCGAATCCGGGTGGGACCCCCA 103 nt 
 
Final Forward: 
AATTCCTGCAGTAATACGACTCACTATAGGTCCTATAGTGTAGTGGTTATCACTTTC 
Final Reverse: 
mUmGGGGGTCCCACCCGGATTCGAACTGGGGTTGTTCGGATCAGAACCGAAAGTGATAA 
 
 
G1U/C72A 
5' Promoter & 3' CCA sequences appended; incorporate G1U/C72A mutations:  
AATTCCTGCAGTAATACGACTCACTATATGTCCTATAGTGTAGTGGTTATCACTTTCGGTTC
TGATCCGAACAACCCCAGTTCGAATCCGGGTGGGACATCCA 103 nt 
 
Final Forward: 
AATTCCTGCAGTAATACGACTCACTATATGTCCTATAGTGTAGTGGTTATCACTTTC 
Final Reverse: 
mUmGGATGTCCCACCCGGATTCGAACTGGGGTTGTTCGGATCAGAACCGAAAGTGATAA 
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G36C 
Promoter & 3' CCA sequence appended; incorporate G36C mutation:  
AATTCCTGCAGTAATACGACTCACTATAGGTCCTATAGTGTAGTGGTTATCACTTTCGGTTC
TCATCCGAACAACCCCAGTTCGAATCCGGGTGGGACCTCCA 103 nt 
 
Final Forward: 
AATTCCTGCAGTAATACGACTCACTATAGGTCCTATAGTGTAGTGGTTATCACTTTC 
Final Reverse: 
mUmGGAGGTCCCACCCGGATTCGAACTGGGGTTGTTCGGATGAGAACCGAAAGTGATAA 
 
 
G2A/C71U 
5' Promoter & 3' CCA sequences appended; incorporate G2A/C71U mutations:  
AATTCCTGCAGTAATACGACTCACTATAGATCCTATAGTGTAGTGGTTATCACTTTCGGTTC
TGATCCGAACAACCCCAGTTCGAATCCGGGTGGGATCTCCA 103 nt 
 
 
Final Forward: 
AATTCCTGCAGTAATACGACTCACTATAGATCCTATAGTGTAGTGGTTATCACTTTC  
Final Reverse: 
mUmGGAGATCCCACCCGGATTCGAACTGGGGTTGTTCGGATCAGAACCGAAAGTGATAA 
 
 
U3G/A70C 
5' Promoter & 3' CCA sequences appended; incorporate U3G/A70C mutations:  
AATTCCTGCAGTAATACGACTCACTATAGGGCCTATAGTGTAGTGGTTATCACTTTCGGTT
CTGATCCGAACAACCCCAGTTCGAATCCGGGTGGGCCCTCCA 103 nt 
 
Final Forward: 
AATTCCTGCAGTAATACGACTCACTATAGGGCCTATAGTGTAGTGGTTATCACTTTC 
Final Reverse: 
mUmGGAGGGCCCACCCGGATTCGAACTGGGGTTGTTCGGATCAGAACCGAAAGTGATAA 
 
 
G10A/C25U 
5' Promoter & 3' CCA sequences appended; incorporate G10A/C25U mutations:  
AATTCCTGCAGTAATACGACTCACTATAGGTCCTATAATGTAGTGGTTATCATTTTCGGTTC
TGATCCGAACAACCCCAGTTCGAATCCGGGTGGGACCTCCA 103 nt 
 
Final Forward: 
AATTCCTGCAGTAATACGACTCACTATAGGTCCTATAATGTAGTGGTTATCATTTTC 
Final Reverse: 
mUmGGAGGTCCCACCCGGATTCGAACTGGGGTTGTTCGGATCAGAACCGAAAATGATAA 
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APPENDIX C - Michaelis-Menten Fits of mutant Sce tRNAQ2 initial rates 
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APPENDIX D - Supplemental Data (SD) file descriptions 
 
 
SD1 (143 KB) - FASTA sequences of Eukaryotic and Bacterial QRS sequences used for 
Figure S1; can be opened with text editor 
 
SD2 (15 KB) - FASTA sequences of Eco tRNA; can be opened with text editor 
 
SD3 (51 KB) - FASTA sequences of Sce tRNA; can be opened with text editor 
 
SD4 (99 KB) - FASTA sequences of Hsa tRNA; can be opened with text editor 
 
SD5 (289,388 KB) - Zip file of raw kinetic data (.gel); requires ImageQuant to open 
 
SD6 (68 KB) - Spreadsheet (.xml) legend to eukaryotic QRS sequences in SD1; requires 
a spreadsheet application to open 
 
 
 
